Researchers will also be focusing on extremely-extended-acting GLP-1 analogs which will need dosing just once a month or perhaps fewer frequently. These extended-release variations could help it become even easier to keep on with having GLP-1s.  Semaglutide imitates the actions of GLP 1 by stimulating insulin production in the pancreatic beta cel